SAB Biotherapeutics, Inc.
SABS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001833214
No open-market purchases or sales by SAB Biotherapeutics, Inc. insiders were filed in the last 90 days; 87 institutions reported holding it in 13F filings for Q2 2026, worth $266.8M in total; no superinvestor holds it.
Other share classesSABSW
13F holders, Q1 2023
Institutional positions in SAB Biotherapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +1 vs. Q4 2022
- Shares held
- 3.87M
- −223.2K (−5.5%) vs. Q4 2022
- Total value
- $1.71M
- −$706.1K (−29.2%) vs. Q4 2022
- New holders
- 7
- 4 more added
- Sold out
- 6
- 7 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SABS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 87 | $266.8M |
| Q1 2026 | 76 | $265.0M |
| Q4 2025 | 48 | $135.9M |
| Q3 2025 | 34 | $56.3M |
| Q2 2025 | 25 | $3.37M |
| Q1 2025 | 26 | $2.99M |
| Q4 2024 | 25 | $10.1M |
| Q3 2024 | 25 | $8.48M |
| Q2 2024 | 22 | $9.69M |
| Q1 2024 | 24 | $15.2M |
| Q4 2023 | 42 | $24.5M |
| Q3 2023 | 34 | $2.41M |
| Q2 2023 | 38 | $3.28M |
| Q1 2023 | 39 | $1.71M |
| Q4 2022 | 38 | $2.42M |
| Q3 2022 | 40 | $2.32M |
| Q2 2022 | 37 | $4.45M |
| Q1 2022 | 27 | $6.71M |
| Q4 2021 | 34 | $25.4M |
| Q3 2021 | 1 | $605.0K |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding SAB Biotherapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First PREMIER Bank | 807,535 | $355.0K | 0.10% | 00.0% | Unchanged |
| Vanguard Group Inc | 701,584 | $308.7K | 0.00% | 00.0% | Unchanged |
| Veritable, L.P. | 506,513 | $222.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 300,529 | $132.2K | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 277,777 | $122.2K | 0.00% | +277,777 | New |
| Warberg Asset Management LLC | 177,659 | $78.2K | 0.02% | −192,711−52.0% | Reduced |
| Institutional & Family Asset Management, LLC | 149,774 | $65.9K | 0.01% | 00.0% | Unchanged |
| Meteora Capital, LLC | 134,524 | $59.2K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 110,013 | $48.4K | 0.00% | +1,860+1.7% | Added |
| Bridgeway Capital Management, LLC | 84,000 | $37.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 81,241 | $35.7K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 73,470 | $32.0K | 0.00% | −2,500−3.3% | Reduced |
| Mariner, LLC | 69,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Silver Oak Securities, Inc | 51,891 | $23.0K | 0.00% | −50−0.1% | Reduced |
| Creative Planning | 47,518 | $20.9K | 0.00% | −1,000−2.1% | Reduced |
| Northern Trust Corp | 44,476 | $19.6K | 0.00% | 00.0% | Unchanged |
| Brookstone Capital Management | 21,755 | $16.8K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 28,400 | $12.5K | 0.00% | −80,815−74.0% | Reduced |
| LGL Partners, LLC | 23,000 | $10.1K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 19,096 | $8.40K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 17,306 | $7.61K | 0.00% | +99+0.6% | Added |
| Charles Schwab Investment Management Inc | 16,238 | $7.14K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 16,062 | $7.00K | 0.00% | +4,651+40.8% | Added |
| Virtu Financial LLC | 15,014 | $7.00K | 0.00% | +15,014 | New |
| Strategic Financial Concepts, LLC | 15,027 | $6.61K | 0.00% | +15,027 | New |
| Nadler Financial Group, Inc. | 13,750 | $6.05K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 13,439 | $5.91K | 0.00% | +13,439 | New |
| Kestra Advisory Services, LLC | 11,000 | $4.84K | 0.00% | 00.0% | Unchanged |
| Baird Financial Group, Inc. | 10,000 | $4.40K | 0.00% | 00.0% | Unchanged |
| 1st Source Bank | 10,000 | $4.40K | 0.00% | 00.0% | Unchanged |
| Elgethun Capital Management | 7,041 | $3.22K | 0.00% | −7,755−52.4% | Reduced |
| UBS Group AG | 6,679 | $2.94K | 0.00% | −248−3.6% | Reduced |
| Royal Bank of Canada | 4,820 | $2.00K | 0.00% | 00.0% | Unchanged |
| Gs Investments, Inc. | 2,000 | $880 | 0.00% | +2,000 | New |
| Harbour Investments, Inc. | 500 | $220 | 0.00% | +500 | New |
| Wells Fargo & Company | 187 | $82 | 0.00% | +2+1.1% | Added |
| GWM Advisors LLC | 145 | $64 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 54 | $24 | 0.00% | +54 | New |
| JPMorgan Chase & Co | 881 | $0 | 0.00% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 0 | $0 | 0.00% | −236,621−100.0% | Sold out |
| AE Wealth Management LLC | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −11,441−100.0% | Sold out |
| Money Concepts Capital Corp | 0 | $0 | 0.00% | −250−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |